Prokineticins in angiogenesis and cancer

Cancer Letters

Volumn 296, Issue 2, 2010, Pages 144-149

  Monnier, Justin ^a   Samson, Michel ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Angiogenesis; Cancer; Chemokine; GPCR; Innate immunity; Prokineticins

Indexed keywords

CHEMOKINE; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PROKINETICIN 2; PROKINETICIN RECEPTOR 1; PROKINETICIN RECEPTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY;

ANTIANGIOGENIC ACTIVITY; BONE MARROW CELL; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; COLORECTAL CANCER; ENDOMETRIUM CARCINOMA; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INSULINOMA; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NEUROBLASTOMA; NONHUMAN; OVARY CARCINOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TESTIS CANCER; TUMOR VASCULARIZATION;

ANURA; MAMMALIA;

EID: 77955274496     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.06.011     Document Type: Review

References (41)

1. Monnier J., Samson M. Cytokine properties of prokineticins. FEBS J. 2008, 275:4014-4021.
2. Mollay C., Wechselberger C., Mignogna G., Negri L., Melchiorri P., Barra D., Kreil G. Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur. J. Pharmacol. 1999, 374:189-196.
3. Schweitz H., Pacaud P., Diochot S., Moinier D., Lazdunski M. MIT(1), a black mamba toxin with a new and highly potent activity on intestinal contraction. FEBS Lett. 1999, 461:183-188.
4. Bullock C.M., Li J.D., Zhou Q.Y. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol. Pharmacol. 2004, 65:582-588.
5. Negri L., Lattanzi R., Giannini E., Melchiorri P. Bv8/prokineticin proteins and their receptors. Life Sci. 2007, 81:1103-1116.
6. Ngan E.S., Tam P.K. Prokineticin-signaling pathway. Int. J. Biochem. Cell Biol. 2008, 40:1679-1684.
7. LeCouter J., Kowalski J., Foster J., Hass P., Zhang Z., Dillard-Telm L., Frantz G., Rangell L., DeGuzman L., Keller G.A., Peale F., Gurney A., Hillan K.J., Ferrara N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001, 412:877-884.
8. Tanaka N., Ikawa M., Mata N.L., Verma I.M. Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration. Mol. Ther. 2006, 13:609-616.
9. LeCouter J., Lin R., Tejada M., Frantz G., Peale F., Hillan K.J., Ferrara N. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc. Natl. Acad. Sci. USA 2003, 100:2685-2690.
10. LeCouter J., Lin R., Frantz G., Zhang Z., Hillan K., Ferrara N. Mouse endocrine gland-derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis. Endocrinology 2003, 144:2606-2616.
11. Guilini C., Urayama K., Turkeri G., Dedeoglu D.B., Kurose H., Messaddeq N., Nebigil C.G. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. Am. J. Physiol. Heart Circ. Physiol. 2009, 298:H844-H852.
12. Battersby S., Critchley H.O., Morgan K., Millar R.P., Jabbour H.N. Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle. J. Clin. Endocrinol. Metab. 2004, 89:2463-2469.
13. Ngan E.S., Lee K.Y., Yeung W.S., Ngan H.Y., Ng E.H., Ho P.C. Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinoma. Endocrinology 2006, 147:88-95.
14. Podlovni H., Ovadia O., Kisliouk T., Klipper E., Zhou Q.Y., Friedman A., Alfaidy N., Meidan R. Differential expression of prokineticin receptors by endothelial cells derived from different vascular beds: a physiological basis for distinct endothelial function. Cell Physiol. Biochem. 2006, 18:315-326.
15. Urayama K., Guilini C., Turkeri G., Takir S., Kurose H., Messaddeq N., Dierich A., Nebigil C.G. Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation. Arterioscler. Thromb. Vasc. Biol. 2008, 28:841-849.
16. Urayama K., Guilini C., Messaddeq N., Hu K., Steenman M., Kurose H., Ert G., Nebigil C.G. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis. Faseb J. 2007, 21:2980-2993.
17. Urayama K., Dedeoglu D.B., Guilini C., Frantz S., Ertl G., Messaddeq N., Nebigil C.G. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage. Cardiovasc. Res. 2009, 81:28-37.
18. Monnier J., Quillien V., Piquet-Pellorce C., Leberre C., Preisser L., Gascan H., Samson M., CCL4 Prokineticin 1 induces CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells. Eur. Cytokine Netw. 2008, 19:166-175.
19. Denison F.C., Battersby S., King A.E., Szuber M., Jabbour H.N. Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta. Endocrinology 2008, 149:3470-3477.
20. Evans J., Catalano R.D., Morgan K., Critchley H.O., Millar R.P., Jabbour H.N. Prokineticin 1 signaling and gene regulation in early human pregnancy. Endocrinology 2008, 149:2877-2887.
21. Nagano H., Goi T., Koneri K., Hirono Y., Katayama K., Yamaguchi A. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) expression in colorectal cancer. J. Surg. Oncol. 2007, 96:605-610.
22. Goi T., Fujioka M., Satoh Y., Tabata S., Koneri K., Nagano H., Hirono Y., Katayama K., Hirose K., Yamaguchi A. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res. 2004, 64:1906-1910.
23. Maldonado-Perez D., Evans J., Denison F., Millar R.P., Jabbour H.N. Potential roles of the prokineticins in reproduction. Trends Endocrinol. Metab. 2007, 18:66-72.
24. Monnier J., Piquet-Pellorce C., Feige J.J., Musso O., Clement B., Turlin B., Theret N., Samson M. Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma. World J. Gastroenterol. 2008, 14:1182-1191.
25. Shojaei F., Wu X., Zhong C., Yu L., Liang X.H., Yao J., Blanchard D., Bais C., Peale F.V., van Bruggen N., Ho C., Ross J., Tan M., Carano R.A., Meng Y.G., Ferrara N. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007, 450:825-831.
26. Ferrara N. Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis. Curr. Opin. Hematol. 2010, 17:219-224.
27. Shojaei F., Singh M., Thompson J.D., Ferrara N. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl. Acad. Sci. USA 2008, 105:2640-2645.
28. Ngan E.S., Lee K.Y., Sit F.Y., Poon H.C., Chan J.K., Sham M.H., Lui V.C., Tam P.K. Prokineticin-1 modulates proliferation and differentiation of enteric neural crest cells. Biochim. Biophys. Acta 2007, 1773:536-545.
29. Ngan E.S., Sit F.Y., Lee K., Miao X., Yuan Z., Wang W., Nicholls J.M., Wong K.K., Garcia-Barcelo M., Lui V.C., Tam P.K. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression. Clin. Cancer Res. 2007, 13:868-875.
30. Ngan E.S., Shum C.K., Poon H.C., Sham M.H., Garcia-Barcelo M.M., Lui V.C., Tam P.K. Prokineticin-1 (Prok-1) works coordinately with glial cell line-derived neurotrophic factor (GDNF) to mediate proliferation and differentiation of enteric neural crest cells. Biochim. Biophys. Acta 2008, 1783:467-478.
31. Kisliouk T., Podlovni H., Meidan R. Unique expression and regulatory mechanisms of EG-VEGF/prokineticin-1 and its receptors in the corpus luteum. Ann. Anat. 2005, 187:529-537.
32. Kisliouk T., Podlovni H., Spanel-Borowski K., Ovadia O., Zhou Q.Y., Meidan R. Prokineticins (endocrine gland-derived vascular endothelial growth factor and BV8) in the bovine ovary: expression and role as mitogens and survival factors for corpus luteum-derived endothelial cells. Endocrinology 2005, 146:3950-3958.
33. Zhang L., Yang N., Conejo-Garcia J.R., Katsaros D., Mohamed-Hadley A., Fracchioli S., Schlienger K., Toll A., Levine B., Rubin S.C., Coukos G. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. Clin. Cancer Res. 2003, 9:264-272.
34. Morales A., Morimoto S., Diaz L., Robles G., Diaz-Sanchez V. Endocrine gland-derived vascular endothelial growth factor in rat pancreas: genetic expression and testosterone regulation. J. Endocrinol. 2008, 197:309-314.
35. Morales A., Vilchis F., Chavez B., Chan C., Robles-Diaz G., Diaz-Sanchez V. Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma. J. Steroid Biochem. Mol. Biol. 2007, 107:37-41.
36. Pasquali D., Rossi V., Staibano S., De Rosa G., Chieffi P., Prezioso D., Mirone V., Mascolo M., Tramontano D., Bellastella A., Sinisi A.A. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinology 2006, 147:4245-4251.
37. Samson M., Peale F.V., Frantz G., Rioux-Leclercq N., Rajpert-De Meyts E., Ferrara N. Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J. Clin. Endocrinol. Metab. 2004, 89:4078-4088.
38. LeCouter J., Zlot C., Tejada M., Peale F., Ferrara N. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc. Natl. Acad. Sci. USA 2004, 101:16813-16818.
39. Bergers G., Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 2008, 8:592-603.
40. Li Q., Xu B., Fu L., Hao X.S. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 2006, 25:403-409.
41. Jiang X., Abiatari I., Kong B., Erkan M., De Oliveira T., Giese N.A., Michalski C.W., Friess H., Kleeff J. Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer. Pancreatology 2009, 9:165-172.